Results 71 to 80 of about 2,123,447 (382)

Desmoid-Type Fibromatosis Associated with Silicone Breast Implants

open access: yes대한영상의학회지, 2019
Desmoid-type fibromatosis (extra-abdominal desmoid tumor) arising in the breast is a rare benign disease entity, accounting for 0.2% of all breast tumors.
Jong Soo Park   +2 more
doaj   +1 more source

Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptation

open access: yesMolecular Oncology, EarlyView.
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani   +14 more
wiley   +1 more source

Liability in the medical sector : the ‘breast-taking’ consequences of the poly implant prothese case [PDF]

open access: yes, 2016
The article deals with the liability of third-party certifiers in the medical sector and especially focuses on the role of TuV Rheinland in the recent Poly Implant Prothese (PIP) breast implant case. The aim of the contribution is twofold.
De Bruyne, Jan, Vanleenhove, Cedric
core  

Aberrant expression of nuclear prothymosin α contributes to epithelial‐mesenchymal transition in lung cancer

open access: yesMolecular Oncology, EarlyView.
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen   +12 more
wiley   +1 more source

Chronic Pulmonary Silicone Embolism Syndrome Following Saline Breast Implants

open access: yesAnnals of Internal Medicine: Clinical Cases, 2023
Chronic pulmonary silicone embolism syndrome (CPSE) presents as progressive dyspnea occurring after silicone prosthesis implantation. Diagnostic criteria for CPSE include imaging findings of intraparenchymal ground-glass opacities and histologic evidence
Jorden E. Smith   +8 more
doaj   +1 more source

Reporting Risk: The Case of Silicone Breast Implants [PDF]

open access: yes, 1994
Professor Nelkin finds journalists to be, if reluctantly, subject to influence and describes their uneasy relationship with scientists in filling a difficult ...
Nelkin, Dorothy
core   +2 more sources

Breast implant illness: a step forward in understanding this complex entity and the impact of social media [PDF]

open access: yes, 2019
Introduction. The number of implant-related complaints is constantly rising, a phenomenon probably accentuated by the extensive use of social media by patients. Material and method.
Ardeleanu, Valeriu   +5 more
core   +2 more sources

Breast implant illness in silicone breast implant patients [PDF]

open access: yes, 2022
This dissertation studied health complaints in Silicone Breast Implant (SBI) patients, known under the term Breast Implant Illness (BII). This is a symptom complex of non-specific health complaints such as muscle pain, joint pain, extreme fatigue, sleep disturbances, pyrexia, dry eyes/dry mouth (sicca) and cognitive disturbances.
openaire   +1 more source

Understanding rare adverse sequelae of breast implants: anaplastic large-cell lymphoma, late seromas, and double capsules.

open access: yesGland surgery, 2017
Breast implant-associated anaplastic large cell lymphoma (BI-ALCL) is a distinct type of T-cell lymphoma arising around breast implants. The United States FDA recently updated the 2011 safety communication, warning that women with breast implants may ...
M. Clemens   +3 more
semanticscholar   +1 more source

Early metastasis is characterized by Gr1+ cell dysregulation and is inhibited by immunomodulatory nanoparticles

open access: yesMolecular Oncology, EarlyView.
Breast cancer metastasis is associated with myeloid cell dysregulation and the lung‐specific accumulation of tumor‐supportive Gr1+ cells. Gr1+ cells support metastasis, in part, through a CHI3L1‐mediated mechanism, which can be targeted and inhibited with cargo‐free, polymeric nanoparticles.
Jeffrey A. Ma   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy